BioSpace News Archive

Affirms commitment to value-based kidney care and improving kidney disease prevention, home dialysis and transplantation

CStone Pharmaceuticals announced that the first patient has been dosed in China with avapritinib in the ongoing global Phase III VOYAGER clinical trial.

Since 2011, ENA has recognized ED excellence in practice and performance

At the 2019 Global Bio Conference, the company released preliminary test results, achieving an ‘almost full regression of pancreatic cancer’ in animal testing

Recros Medica, Inc., today announced that the US Patent and Trademark Office (USPTO) has issued a new patent for a novel application to treat patients’ aesthetic defects with their own skin

Researchers at Baylor College of Medicine and Medterra CBD, one of the leaders in the CBD category, announced a collaborative study to explore the verifiable effects of cannabidiol (CBD), a THC-free product derived from the cannabis plant, with the hope of deriving a scientifically accurate viewpoint regarding CBD and its biological capabilities.

Trading in WYG shares on the London Stock Exchange has been suspended and the outstanding shares of WYG are now owned by Tetra Tech.

If Yvonne and Claudio Yanes, the parents of Alonzo Yanes, could say one thing to the New York City Department of Education it would be this: There is nothing more important than the safety of our children.

Patient Innovations, an innovative New York based healthcare IT company supporting physicians and health systems, has announced the appointment of John M. Tabone as Chairman and CEO.

Microphyt, a leading company in microalgae-based natural solutions for nutrition and well-being, announced a fundraising of €28.5 million (US$32 million).